APA (7th ed.) Citation

N, S., H, Y., & BA, N. (2025). Metabolic dysfunction-associated steatotic liver disease: Heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. The lancet. Diabetes & endocrinology, 13(2), 134. https://doi.org/10.1016/S2213-8587(24)00318-8

Chicago Style (17th ed.) Citation

N, Stefan, Yki-Järvinen H, and Neuschwander-Tetri BA. "Metabolic Dysfunction-associated Steatotic Liver Disease: Heterogeneous Pathomechanisms and Effectiveness of Metabolism-based Treatment." The Lancet. Diabetes & Endocrinology 13, no. 2 (2025): 134. https://doi.org/10.1016/S2213-8587(24)00318-8.

MLA (9th ed.) Citation

N, Stefan, et al. "Metabolic Dysfunction-associated Steatotic Liver Disease: Heterogeneous Pathomechanisms and Effectiveness of Metabolism-based Treatment." The Lancet. Diabetes & Endocrinology, vol. 13, no. 2, 2025, p. 134, https://doi.org/10.1016/S2213-8587(24)00318-8.